Comparing Daridorexant vs Eszopiclone
| Daridorexant | Eszopiclone |
|
|---|
| Daridorexant | Eszopiclone |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Insomnia. Daridorexant may also be used for purposes not listed in this medication guide. |
Prescription only
Eszopiclone induces and helps maintain sleep; however, it has been associated with unusual behaviors such as sleep-driving or food-making and consumption while asleep. In some people, effects persist... View more |
Related suggestions Insomnia
|
|||||||
| More about Daridorexant | More about Eszopiclone | ||||||||
| Ratings & Reviews | |||||||||
|
Daridorexant has an average rating of 5.3 out of 10 from a total of 164 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 44% reported a negative effect. |
Eszopiclone has an average rating of 5.7 out of 10 from a total of 443 ratings on Drugs.com. 43% of reviewers reported a positive effect, while 37% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Daridorexant side effects |
View all Eszopiclone side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
Lower cost generic |
||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Eszopiclone prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Quviviq | Lunesta | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
8 hours |
6 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
Some potential for abuse
Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 680 drugs are known to interact with Daridorexant:
|
A total of 384 drugs are known to interact with Eszopiclone:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
January 07, 2022 |
N/A |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.